Suchergebnisse - "antibodies"

PubPharm (1.606)

1

Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial

enthalten in: Vaccine | 2024

von Baum, H. | Thirard, R. | Halliday, A. | +13

2

Immunogenicity and safety of Sinovac-CoronaVac booster vaccinations in 12-17- year-olds with clinically significant reactions from Pfizer-BNT162b2 vaccination

enthalten in: Vaccine | 2024

von Chong, C. | Kam, K. | Zhang, J. | +8

3

The humoral immune response to the BNT 162B2 vaccine in pediatrics on renal replacement therapy

enthalten in: Pediatric transplantation | 2024

von Alshami, A. | Bahbah, H. | Al Attas, R. | +2

4

Prevalence of neutralizing antibodies against SARS-CoV-2 using a rapid serological test in health workers of a Spanish Department of Health in Alicante (Spain) before the booster dose of the vaccine

enthalten in: Revista clinica espanola | 2024

von Montagud, A. | Llenas-García, J. | Moragues, R. | +7

5

Altered transcriptomic immune responses of maintenance hemodialysis patients to the COVID-19 mRNA vaccine

enthalten in: eLife | 2024

von Chang, Y. | Huang, K. | Lee, J. | +22

6

Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination

enthalten in: BMC infectious diseases | 2024

von Hönning, A. | Tomczyk, S. | Hermes, J. | +9

7

An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation

enthalten in: Nature communications | 2024

von Park, S. | Choi, J. | Lee, Y. | +14

8

Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years : a prospective, observational cohort study

enthalten in: Scientific reports | 2024

von Gaultier, G. | McMillan, B. | Poloni, C. | +18

9

Immune response stability to the SARS-CoV-2 mRNA vaccine booster is influenced by differential splicing of HLA genes

enthalten in: Scientific reports | 2024

von Santos-Rebouças, C. | Ferreira, C. | Nogueira, J. | +8

10

The varying extent of humoral and cellular immune responses to either vector- or RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent of infection

enthalten in: Journal of virology | 2024

von Mai, F. | Bergmann, W. | Reisinger, E. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[161]